Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer Research|November 24, 2021
Current and Future Clinical Applications of ctDNA in Immuno-OncologyJulia-Christina Stadler, Yassine Belloum, Benjamin Deitert, et al.
Cancers|February 5, 2021
Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer CellsKai Bartkowiak, Isabel Heidrich, Marcel Kwiatkowski, et al.
GMS Journal for Medical Education|October 17, 2025
Implementation of a team-teaching seminar on the stigmatization and psychosocial burdens of people with visible skin diseases in the standard curriculum of medical studiesInes Heinen, Rachel Sommer, Inga Hansen-Abeck, et al.
Plos One|February 18, 2026
Testing undergraduate medical students' ability to correctly identify skin conditions in skin of color-A pre-post-study at a medical school in GermanyFinn Abeck, Ines Heinen, Isabel Heidrich, et al.
Cancers|September 13, 2025
Comprehensive Assessment of Prognostic Factors for Immune-Related Adverse Events in Immune Checkpoint Inhibitor-Treated MelanomaJulian Kött, Myriam Merkle, Lina Bergmann, et al.
Cancers|July 12, 2025
Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell CarcinomaGlenn Geidel, Laura Adam, Sabrina Bänsch, et al.
Cancers|May 11, 2024
High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving ImmunotherapyJulian Kött, Inka Lilott Hoehne, Isabel Heidrich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2024
Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanomaGlenn Geidel, Niousha Parnian, Christian Meß, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2024
Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsyJulian Kött, Noah Zimmermann, Tim Zell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanomaEgle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Pageof 4